Oscar Health, Inc.
OSCR
$18.02
-$0.07-0.39%
| Weiss Ratings | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.64 | |||
| Price History | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 5.86% | |||
| 30-Day Total Return | 18.09% | |||
| 60-Day Total Return | 31.39% | |||
| 90-Day Total Return | 110.63% | |||
| Year to Date Total Return | 80.77% | |||
| 1-Year Total Return | 181.20% | |||
| 2-Year Total Return | 113.36% | |||
| 3-Year Total Return | -30.39% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -3.56% | |||
| 52-Week Low % Change | 279.03% | |||
| Price | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $18.55 | |||
| 52-Week Low Price | $4.72 | |||
| 52-Week Low Price (Date) | Oct 30, 2023 | |||
| 52-Week High Price (Date) | Feb 15, 2024 | |||
| Valuation | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.67B | |||
| Enterprise Value | 2.18B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.21 | |||
| Earnings Per Share Growth | -57.53% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.62 | |||
| Price/Book (Q) | 4.56 | |||
| Enterprise Value/Revenue (TTM) | 0.47 | |||
| Price | $16.45 | |||
| Enterprise Value/EBITDA (TTM) | -13.40 | |||
| Enterprise Value/EBIT | -11.65 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 227.08M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 646 403 3677 | |||
| Address | 75 Varick Street New York, NY 10013 | |||
| Website | www.hioscar.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -4.01% | |||
| Profit Margin | -4.61% | |||
| Management Effectiveness | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -3.62% | |||
| Return on Equity | -- | |||
| Income Statement | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 5.86B | |||
| Total Revenue (TTM) | 5.86B | |||
| Revenue Per Share | $25.81 | |||
| Gross Profit (TTM) | 1.22B | |||
| EBITDA (TTM) | -204.92M | |||
| EBIT (TTM) | -235.62M | |||
| Net Income (TTM) | -270.73M | |||
| Net Income Avl. to Common (TTM) | -270.73M | |||
| Total Revenue Growth (Q YOY) | 41.77% | |||
| Earnings Growth (Q YOY) | 33.86% | |||
| EPS Diluted (TTM) | -1.21 | |||
| EPS Diluted Growth (Q YOY) | 37.10% | |||
| Balance Sheet | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.56B | |||
| Cash Per Share (Q) | $11.27 | |||
| Total Current Assets (Q) | 3.06B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 806.12M | |||
| Current Ratio (Q) | 1.260 | |||
| Book Value Per Share (Q) | $3.51 | |||
| Total Assets (Q) | 3.60B | |||
| Total Current Liabilities (Q) | 2.43B | |||
| Total Debt (Q) | 379.76M | |||
| Total Liabilities (Q) | 2.80B | |||
| Total Common Equity (Q) | 803.97M | |||
| Cash Flow | OSCR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 577.19M | |||
| Cash from Financing (TTM) | 6.45M | |||
| Net Change in Cash (TTM) | 311.47M | |||
| Levered Free Cash Flow (TTM) | 558.82M | |||
| Cash from Operations (TTM) | -272.16M | |||
